Fundz

Senti Biosciences reported raising $37.6 Million in an initial SEC Form D filing, from an offering of $121 Million

PUBLIC · SNTIDec 19, 2024$37.6M of $120.6M raised

Amount Raised

$37.6 Million

$37.6 Million sold, per SEC Form D (first sale Dec 9, 2024)

Round Type

Venture

South San FranciscoBiotechnology

Investors

New Enterprise Associates

Who else raised in Biotechnology around the same time

Companies in the same sectors as Senti Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K (Pre-Seed) on January 23, 2025.
  • MED-X raised $428K on January 23, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • SVASTEK raised $231K (Seed) on January 23, 2025.
  • Nuclein raised $750K (Seed) on January 23, 2025.
  • Resynergi raised $18M on January 23, 2025.

Who to call at Senti Biosciences, and when

A new round usually means Senti Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Senti Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Senti Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Senti Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Senti Biosciences

Location

2 Corporate Drive, First Floor

South San Francisco, California, United States

About

Senti Biosciences, Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Senti Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsFaraz S., Senior Vice President, Technical Operat… hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Senti Biosciences's next move

See what Strategic adds

Senti Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.